Design of fructose-2,6-bisphosphatase inhibitors: A novel virtual screening approach

Journal of Molecular Graphics and Modelling

Volumn 26, Issue 6, 2008, Pages 900-906

  Shaikh, M S ^a   Mittal, Amit ^a   Bharatam, P V ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Diabetes Mellitus; Fructose 2,6 bisphosphatase; Molecular docking; Pharmacophore mapping; Virtual screening

Indexed keywords

DIABETES MELLITUS; MOLECULAR DOCKING; PHARMACOPHORE MAPPING; VIRTUAL SCREENING;

DRUG INTERACTIONS; FRUCTOSE; GLYCOLS; MEDICAL PROBLEMS; MOLECULAR ORIENTATION;

ENZYMES;

BTB 05499; ENZYME INHIBITOR; FRUCTOSE 2,6 BISPHOSPHATASE; FRUCTOSE 2,6 BISPHOSPHATASE INHIBITOR; FRUCTOSE 6 PHOSPHATE; HTS 02332; HTS 04937; HTS 08532; KM 06874; RDR 02080; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; GLUCONEOGENESIS; GLYCOLYSIS; PHARMACOPHORE; PRIORITY JOURNAL;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; ENZYME INHIBITORS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PHOSPHOFRUCTOKINASE-2;

RATTUS;

EID: 37349070011     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2007.06.004     Document Type: Article

References (54)

1. Wu C., Okar D.A., Newgard C.B., and Lange A.J. J. Clinic. Invest. 107 (2001) 91
2. Perez J.X., Roig T., Manzano A., Dalmau M., Boada J., Ventura F., and Rosa J.L. Am. J. Physiol. Cell. Physiol. 279 (2000) C1359
3. Stewart H.B., El-Maghrabi M.R., and Pilkis S.J. J. Biol. Chem. 261 (1986) 8793
4. Furuya E., Yokoyama M., and Uyeda K. Biochem. Biophys. Res. Commun. 105 (1982) 264
5. Nishimura M., and Uyeda K. J. Biol. Chem. 270 (1995) 26341
6. Zhu Z., Ling S., Yang Q.H., and Li L. Biochem. J. 357 (2001) 513
7. Yang Q.H., Zhu Z., Dong M.Q., Ling S., Wu C.L., and Li L. J. Biol. Chem. 276 (2001) 24608
8. Goldstein B.N., and Maevsky A.A. FEBS Lett. 532 (2002) 295
9. Choi I.Y., Wu C., Okar D.A., Lange A.J., and Gruetter R. Eur. J. Biochem. 269 (2002) 4418
10. Wu C., Okar D.A., Newgard C.B., and Lange A.J. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E38
11. Okar D.A., Manzano A., Navarro-Sabate A., Riera L., Bartrons R., and Lange A.J. Trends Biochem. Sci. 26 (2001) 30
12. Pilkis S.J., Pilkis J., El-Maghrabi M.R., and Claus T.H. J. Biol. Chem. 260 (1985) 7551
13. Villadsen D., and Nielsen T.H. Biochem. J. 359 (2001) 591
14. Rider M.H., Bartrons R., and Hue L. Eur. J. Biochem. 190 (1990) 53
15. Rider M.H., and Hue L. Biochem. J. 262 (1989) 97
16. El-Maghrabi M.R., Pate T.M., Murray K.J., and Pilkis S.J. J. Biol. Chem. 259 (1984) 13096
17. El-Maghrabi M.R., and Pilkis S.J. J. Cell. Biochem. 26 (1984) 1
18. Waszkowycz B., Perkins T.D.J., Sykes R.A., and Li J. IBM Syst. J. 40 (2001) 360
19. Lengauer T., Lemmen C., Rarey M., and Zimmermann A.M. Drug Discov. Today 9 (2004) 27
20. Wolber G., and Langer T.J. Chem. Inf. Model. 45 (2005) 160
21. Guner O.F. Curr. Top. Med. Chem. 2 (2002) 1321
22. Koh J.T. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6902
23. Silverman R.B. Irreversible enzyme inhibitors. In: Hayhurst J. (Ed). The Organic Chemistry of Drug Design and Drug Action (1992), Elsevier Academic Press, San Diego, CA 188
24. E.C. Weissttein, Conjugate Gradient Method, from Mathworld-A Wolfram Web Resource, http://mathworld.Wolfram.com/ConjugateGradientMethod.html.
25. Clark M., Cramer III R.D., and Van O.N. J. Comput. Chem. 10 (1989) 982
26. Rarey M., Kramer B., and Lenguaer T. J. Comput. Aided Mol. Des. 11 (1997) 369
27. SYBYL 6.9, Tripos, Inc., St. Louis, MO.
28. Yuen M.H., Mizuguchi H., Lee Y.H., Cook P.F., and Uyeda K. J. Biol. Chem. 274 (1999) 2176
29. Lin K., Li L., Correia J.J., and Pilkis S.J. J. Biol. Chem. 267 (1992) 6556
30. Li L., Lin K., Correia J.J., and Pilkis S.J. J. Biol. Chem. 267 (1992) 21588
31. Böhm H.J. J. Comput. Aided Mol. Des. 8 (1994) 243
32. Böhm H.J. J. Comput. Aided Mol. Des. 12 (1998) 309
33. Wang R., Lai L., and Wang S. J. Comput. Aided Mol. Des. 16 (2002) 11
34. Muegge I., and Martin Y.C. J. Med. Chem. 42 (1999) 791
35. Muegge I. Persp. Drug Discov. Des. 20 (2000) 99
36. Muegge I. J. Comput. Chem. 22 (2001) 418
37. Kramer B., Rarey M., and Lengauer T. Proteins 37 (1999) 228
38. Eldridge M.D., Murray C.W., Auton T.R., Paolini G.V., and Mee R.P. J. Comput. Aided Mol. Des. 11 (1997) 425
39. UNITY Chemical Information Software, Version 4.4, Tripos, Inc., St. Louis, MO.
40. Sakata J., and Uyeda K. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4951
41. Tauler A., Lin K., and Pilkis S.J. J. Biol. Chem. 265 (1990) 15617
42. Kitajima S., Sakakibara R., and Uyeda K. J. Biol. Chem. 259 (1984) 6896
43. LeadQuest Chemical Compound Libraries vols. 1-3 (2000), Tripos, Inc., St. Louis, MO
44. http://leadquest.tripos.com
45. Maybridge Database (1999), Maybridge Chemical Co., Ltd., U.K.
46. http://www.daylight.com/products/databases/Maybridge.html
47. Voigt J.H., Bienfait B., Wang S., and Nicklaus M.C. J. Chem. Inf. Comput. Sci. 41 (2001) 702
48. Shi L.M., Fan Y., Lee J.K., Waltham M., Andrews D.T., Scherf U., Paull K.D., and Weinstein J.N. J. Chem. Inf. Comput. Sci. 40 (2000) 367
49. http://cactus.nci.nih.gov
50. Muegge I. Med. Res. Rev. 23 (2003) 302
51. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P. J. Adv. Drug Del. Res. 23 (1997) 3
52. Teague S.J., Davis A.M., Leeson P.D., and Oprea T. Angew. Chem. Int. Ed. 38 (1999) 3743
53. Oprea T.I., Davis A.M., Teague S.J., and Leeson P.D. J. Chem. Inf. Comput. Sci. 41 (2001) 1308
54. Proudfoot J.R. Bioorg. Med. Chem. Lett. 12 (2002) 1647